# Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC)

> **NCT06057298** · NA · UNKNOWN · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 24 (estimated)

## Conditions studied

- Peritoneal Metastases From Colorectal Cancer

## Interventions

- **PROCEDURE:** Patient-tailored hyperthermic intraperitoneal chemotherapy (HIPEC)

## Key facts

- **NCT ID:** NCT06057298
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-15
- **Primary completion:** 2025-06-14
- **Final completion:** 2025-06-14
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06057298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06057298, "Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06057298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*